"Carolina Eye Associates is one of the largest eye care providers in the Southeast. Thirteen regional centers provide care to patients from across the U.S. and more than 20 foreign countries. We offer a fully accredited eye surgery center in both our Greensboro and Southern Pines/Pinehurst locations. Established in Southern Pines, N.C. in 1977, Carolina Eye offers a full range of high-quality medical and surgical eye care services. Using state-of-the-art technology and eye care practices, our doctors and staff provide the finest treatment, individual attention and compassionate care to patients."

During the past decade, Carolina Eye Associates conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Carolina Eye Associates" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "OccuLogix" with 2 trials sponsored, "Alcon Research" with 1 trials sponsored, "Allergan" with 1 trials sponsored and "Formosa Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Carolina Eye Associates" #1 collaborator was "Novartis" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Carolina Eye Associates" are "Macular Degeneration" (3 trials), "Diabetic Macular Edema" (2 trials), "Keratoconjunctivitis Sicca" (1 trials), "Ocular Inflammation and Pain" (1 trials) and "Primary Open Angle Glaucoma" (1 trials). Many other conditions were trialed in "Carolina Eye Associates" in a lesser frequency.

Most popular intervention types in "Carolina Eye Associates" are "Drug" (7 trials), "Device" (3 trials), "Procedure" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Aflibercept" (2 trials), "Rheopheresis blood filtration" (2 trials) and "APP13007, 0.05%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Carolina Eye Associates" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Carolina Eye Associates". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Carolina Eye Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Carolina Eye Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".